JP2009517468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517468A5 JP2009517468A5 JP2008543278A JP2008543278A JP2009517468A5 JP 2009517468 A5 JP2009517468 A5 JP 2009517468A5 JP 2008543278 A JP2008543278 A JP 2008543278A JP 2008543278 A JP2008543278 A JP 2008543278A JP 2009517468 A5 JP2009517468 A5 JP 2009517468A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- disease
- active ingredient
- rivastigmine
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- HIBWGGKDGCBPTA-UHFFFAOYSA-N C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 HIBWGGKDGCBPTA-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Natural products CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 229940108366 exelon Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- -1 polydimethylsiloxane Polymers 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229960004136 rivastigmine Drugs 0.000 description 1
- 229950010673 rivastigmine hydrogen tartrate Drugs 0.000 description 1
- 229960004323 rivastigmine tartrate Drugs 0.000 description 1
- GWHQHAUAXRMMOT-MBANBULQSA-N rivastigmine tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 GWHQHAUAXRMMOT-MBANBULQSA-N 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74151105P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/039557 WO2007064407A1 (en) | 2005-12-01 | 2006-10-10 | Transdermal therapeutic system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013107198A Division JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517468A JP2009517468A (ja) | 2009-04-30 |
| JP2009517468A5 true JP2009517468A5 (enExample) | 2009-11-26 |
Family
ID=37716856
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008543278A Withdrawn JP2009517468A (ja) | 2005-12-01 | 2006-10-10 | 経皮吸収治療システム |
| JP2013107198A Active JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
| JP2015233544A Active JP6298034B2 (ja) | 2005-12-01 | 2015-11-30 | 経皮吸収治療システム |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013107198A Active JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
| JP2015233544A Active JP6298034B2 (ja) | 2005-12-01 | 2015-11-30 | 経皮吸収治療システム |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US20070128263A1 (enExample) |
| EP (5) | EP1959937A1 (enExample) |
| JP (3) | JP2009517468A (enExample) |
| KR (7) | KR20180050441A (enExample) |
| CN (2) | CN102048713A (enExample) |
| AR (2) | AR057152A1 (enExample) |
| AT (1) | AT11185U1 (enExample) |
| AU (1) | AU2006320919B2 (enExample) |
| BR (2) | BR122013013162A2 (enExample) |
| CA (1) | CA2563110A1 (enExample) |
| DE (2) | DE202006021172U1 (enExample) |
| DK (5) | DK2292219T3 (enExample) |
| EC (1) | ECSP088469A (enExample) |
| ES (1) | ES2414455T3 (enExample) |
| FI (1) | FI10268U1 (enExample) |
| GT (1) | GT200800075A (enExample) |
| IL (4) | IL191311A (enExample) |
| MA (1) | MA30022B1 (enExample) |
| MY (2) | MY151020A (enExample) |
| NO (1) | NO20082753L (enExample) |
| NZ (1) | NZ568273A (enExample) |
| PH (2) | PH12013500772B1 (enExample) |
| PL (1) | PL2292219T4 (enExample) |
| PT (1) | PT2292219E (enExample) |
| RU (1) | RU2450805C2 (enExample) |
| SG (1) | SG2014014989A (enExample) |
| SI (1) | SI2292219T1 (enExample) |
| TN (1) | TNSN08238A1 (enExample) |
| TW (1) | TWI389709B (enExample) |
| WO (1) | WO2007064407A1 (enExample) |
| ZA (1) | ZA200803882B (enExample) |
Families Citing this family (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB0823554D0 (en) | 2008-12-24 | 2009-01-28 | Novartis Ag | Process for the preparation of optically active compounds using transfer hydrogenation |
| EP2419485B1 (en) * | 2009-04-17 | 2018-05-23 | 3M Innovative Properties Company | Silicone gel adhesive construction |
| WO2010129689A1 (en) * | 2009-05-05 | 2010-11-11 | Forest Laboratories Holdings Limited | Milnacipran formulations |
| EP2493457B1 (en) | 2009-10-30 | 2017-08-09 | IX Biopharma Ltd | Fast dissolving solid dosage form |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
| WO2011073362A1 (en) | 2009-12-18 | 2011-06-23 | Novartis Ag | Process for the preparation of optically active compounds using pressure hydrogenation |
| US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| US8962014B2 (en) * | 2009-12-22 | 2015-02-24 | Acino Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| RU2578971C2 (ru) * | 2010-06-17 | 2016-03-27 | Лтс Ломанн Терапи-Системе Аг | Трансдермальное введение мемантина |
| DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
| EP3517105B8 (en) | 2010-07-21 | 2021-06-23 | Kindeva Drug Delivery L.P. | Transdermal adhesive compositions, devices, and methods |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| US20120046383A1 (en) * | 2010-08-19 | 2012-02-23 | Terumo Kabushiki Kaisha | Silicone rubber composition |
| EP3431485B2 (en) | 2010-10-01 | 2024-09-04 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| RS54173B1 (sr) * | 2010-12-14 | 2015-12-31 | Acino Ag | Transdermalni terapijski sistem za davanje aktivne supstance |
| KR101788802B1 (ko) * | 2010-12-24 | 2017-10-20 | 주식회사 삼양바이오팜 | 리바스티그민을 함유하는 경피흡수제제 |
| KR101054317B1 (ko) * | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
| KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
| WO2012135805A2 (en) | 2011-03-31 | 2012-10-04 | modeRNA Therapeutics | Delivery and formulation of engineered nucleic acids |
| BR112013029945A2 (pt) * | 2011-05-20 | 2017-01-31 | Sk Chemicals Co Ltd | emplastro contendo rivastigmina |
| KR20120130073A (ko) * | 2011-05-20 | 2012-11-28 | 에스케이케미칼주식회사 | 리바스티그민 함유 패취 |
| CN103796645B (zh) | 2011-08-31 | 2017-06-20 | 东洋油墨Sc控股株式会社 | 贴剂 |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2763701B1 (en) | 2011-10-03 | 2018-12-19 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| RS62297B1 (sr) | 2011-11-23 | 2021-09-30 | Therapeuticsmd Inc | Prirodne kombinovane hormonske supstitucione formulacije i terapije |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| KR20140102759A (ko) | 2011-12-16 | 2014-08-22 | 모더나 세라퓨틱스, 인코포레이티드 | 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물 |
| KR101399035B1 (ko) * | 2011-12-22 | 2014-05-28 | 주식회사 트랜스덤 | 리바스티그민을 함유하는 경피흡수제제 |
| DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| CN107441069A (zh) | 2012-02-28 | 2017-12-08 | 日绊株式会社 | 贴附剂 |
| WO2013142339A1 (en) | 2012-03-23 | 2013-09-26 | Novartis Ag | Transdermal therapeutic system and method |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| DE18200782T1 (de) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
| US20150051559A1 (en) * | 2012-04-05 | 2015-02-19 | Sparsha Pharma International Private Limited | Transdermal patch for treatment of dementia or alzheimer type dementia |
| PL2859892T3 (pl) * | 2012-06-12 | 2023-10-16 | KM Transderm Ltd. | Plaster |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014028049A1 (en) * | 2012-08-15 | 2014-02-20 | Dow Corning Corporation | Multi - layer transdermal drug delivery system |
| EP2893927A4 (en) * | 2012-09-03 | 2016-03-09 | Nipro Patch Co Ltd | SKIN PATCH |
| KR20140038237A (ko) * | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
| US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
| WO2014051128A1 (ja) * | 2012-09-28 | 2014-04-03 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片 |
| CA2892529C (en) | 2012-11-26 | 2023-04-25 | Moderna Therapeutics, Inc. | Terminally modified rna |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| RU2560668C2 (ru) * | 2013-03-04 | 2015-08-20 | Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" | Трансдермальный седативный фармацевтический гель для лечения психоэмоциальных расстройств |
| AR095259A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| CA2906796A1 (en) * | 2013-03-15 | 2014-09-25 | Nal Pharmaceuticals Ltd. | Transdermal drug delivery system containing rivastigmine |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| TWI745577B (zh) * | 2013-06-12 | 2021-11-11 | 日商Ｋｍ特蘭斯達股份有限公司 | 經皮吸收製劑 |
| PL3040068T3 (pl) | 2013-06-12 | 2022-01-10 | KM Transderm Ltd. | Arkusz samoprzylepny do zastosowania na skórę i kompozycja o absorpcji przezskórnej zastosowana w nim |
| CA2916183C (en) | 2013-07-03 | 2022-03-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with electronic component |
| EA201690675A1 (ru) | 2013-10-03 | 2016-08-31 | Модерна Терапьютикс, Инк. | Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности |
| TWI704933B (zh) | 2013-10-07 | 2020-09-21 | 美商帝國製藥美國股份有限公司 | 右美托咪啶經皮輸送裝置及使用其之方法 |
| CN105764496B (zh) | 2013-10-07 | 2020-09-25 | 帝国制药美国公司 | 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物 |
| TWI709417B (zh) | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| US20160374956A1 (en) | 2013-12-12 | 2016-12-29 | Hisamitsu Pharmaceutical Co., Inc. | Multilayer type patch |
| CN103877063A (zh) * | 2014-03-24 | 2014-06-25 | 张绪伟 | 一种重酒石酸卡巴拉汀胶囊及其制备方法 |
| CN106413695B (zh) | 2014-04-08 | 2019-12-10 | 帝国制药美国公司 | 利伐斯的明透皮组合物及其使用方法 |
| WO2015174502A1 (ja) | 2014-05-15 | 2015-11-19 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
| CA2948219C (en) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
| JP6573913B2 (ja) | 2014-05-20 | 2019-09-11 | エルテーエス ローマン テラピー−ジステーメ アーゲー | ロチゴチンを含む経皮送達システム |
| US11752110B2 (en) | 2014-05-20 | 2023-09-12 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
| JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 天然の併用ホルモン補充療法剤及び療法 |
| CN204119542U (zh) | 2014-09-24 | 2015-01-21 | 上海荣威塑胶工业有限公司 | 一种ptc加热器 |
| CN104523656A (zh) * | 2014-11-20 | 2015-04-22 | 美吉斯制药（厦门）有限公司 | 一种卡巴拉汀缓释透皮贴剂及其制备方法 |
| ES3009434T3 (en) | 2014-12-05 | 2025-03-26 | Km Transderm Ltd | Adhesive sheet for attachment to skin and percutaneous absorption preparation using same |
| DE102015107743A1 (de) | 2015-05-18 | 2016-11-24 | Bsn Medical Gmbh | Silikongelbeschichtete adhäsive Schichtstruktur |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| US9980921B2 (en) * | 2016-06-30 | 2018-05-29 | Taho Pharmaceuticals Ltd. | Transdermal delivery system containing methylphenidate or its salts and methods thereof |
| WO2018038022A1 (ja) | 2016-08-22 | 2018-03-01 | 救急薬品工業株式会社 | 貼付剤 |
| KR102506333B1 (ko) * | 2016-12-20 | 2023-03-06 | 에르테에스 로만 테라피-시스테메 아게 | 아세나핀을 함유하는 경피흡수 치료 시스템 |
| CN110087641B (zh) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统 |
| KR102033686B1 (ko) | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
| WO2019048425A1 (en) | 2017-09-05 | 2019-03-14 | Lts Lohmann Therapie-Systeme Ag | TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL DELIVERY OF RIVASTIGMINE |
| EP3764997A1 (en) * | 2018-03-13 | 2021-01-20 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| WO2019175101A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| BR112020018300A2 (pt) * | 2018-03-13 | 2020-12-22 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico |
| CA3101418A1 (en) * | 2018-06-19 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing rivastigmine |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| US12151030B2 (en) | 2019-01-31 | 2024-11-26 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| JP7549641B2 (ja) * | 2019-07-09 | 2024-09-11 | エルテーエス ローマン テラピー－ジステーメ アーゲー | シリコーン含有ポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム |
| WO2021005118A1 (en) * | 2019-07-09 | 2021-01-14 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
| DE112024000733T5 (de) * | 2023-02-01 | 2025-11-13 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches system zur transdermalen verabreichung von huperzin a |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
| US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
| US5252335A (en) * | 1989-07-12 | 1993-10-12 | Cygnus Therapeutic Systems | Transdermal administration of lisuride |
| DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
| US6316023B1 (en) | 1998-01-12 | 2001-11-13 | Novartis Ag | TTS containing an antioxidant |
| GB9800526D0 (en) * | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
| AU1585601A (en) * | 1999-11-04 | 2001-05-14 | Xel Herbaceuticals | Transdermal administration of huperzine |
| US20020192243A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
| US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| AU2002235155A1 (en) * | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
| DE10103860B4 (de) | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| US20030060423A1 (en) * | 2001-08-30 | 2003-03-27 | Plata-Salaman Carlos R. | Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors |
| DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
| DE60324788D1 (de) * | 2002-05-31 | 2009-01-02 | Lundbeck & Co As H | Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit |
| CN100339070C (zh) * | 2002-10-24 | 2007-09-26 | 莫茨药物股份两合公司 | 包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物 |
| CA2555386A1 (en) | 2004-02-19 | 2005-09-01 | Novartis Ag | Use of cholinesterase inhibitors for treating vascular depression |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| EP2596889B1 (en) * | 2011-11-23 | 2017-04-26 | Sandvik Intellectual Property AB | A cutting insert and a milling tool |
-
2006
- 2006-10-05 TW TW095137245A patent/TWI389709B/zh not_active IP Right Cessation
- 2006-10-10 NZ NZ568273A patent/NZ568273A/en not_active IP Right Cessation
- 2006-10-10 PL PL10179085T patent/PL2292219T4/pl unknown
- 2006-10-10 CN CN2011100034841A patent/CN102048713A/zh active Pending
- 2006-10-10 AU AU2006320919A patent/AU2006320919B2/en not_active Ceased
- 2006-10-10 US US11/539,979 patent/US20070128263A1/en not_active Abandoned
- 2006-10-10 PT PT101790855T patent/PT2292219E/pt unknown
- 2006-10-10 MY MYPI20081730 patent/MY151020A/en unknown
- 2006-10-10 CA CA002563110A patent/CA2563110A1/en active Pending
- 2006-10-10 KR KR1020187012945A patent/KR20180050441A/ko not_active Ceased
- 2006-10-10 EP EP06816633A patent/EP1959937A1/en not_active Withdrawn
- 2006-10-10 RU RU2008126459/15A patent/RU2450805C2/ru active
- 2006-10-10 JP JP2008543278A patent/JP2009517468A/ja not_active Withdrawn
- 2006-10-10 SI SI200631618T patent/SI2292219T1/sl unknown
- 2006-10-10 KR KR1020217001087A patent/KR20210008440A/ko not_active Ceased
- 2006-10-10 KR KR1020177006994A patent/KR20170033449A/ko not_active Ceased
- 2006-10-10 DE DE202006021172U patent/DE202006021172U1/de not_active Ceased
- 2006-10-10 KR KR1020227039266A patent/KR20220156666A/ko not_active Ceased
- 2006-10-10 BR BRBR122013013162-0A patent/BR122013013162A2/pt not_active Application Discontinuation
- 2006-10-10 EP EP17155300.1A patent/EP3235495A1/en not_active Ceased
- 2006-10-10 EP EP10179085.5A patent/EP2292219B9/en not_active Revoked
- 2006-10-10 DK DK10179085.5T patent/DK2292219T3/da active
- 2006-10-10 AR ARP060104447A patent/AR057152A1/es not_active Application Discontinuation
- 2006-10-10 DE DE14163637.3T patent/DE14163637T1/de active Pending
- 2006-10-10 BR BRPI0619758-2A patent/BRPI0619758A2/pt not_active Application Discontinuation
- 2006-10-10 KR KR1020147010333A patent/KR20140072108A/ko not_active Withdrawn
- 2006-10-10 CN CNA2006800434220A patent/CN101312717A/zh active Pending
- 2006-10-10 WO PCT/US2006/039557 patent/WO2007064407A1/en not_active Ceased
- 2006-10-10 EP EP10179084A patent/EP2286802A1/en not_active Withdrawn
- 2006-10-10 ES ES10179085T patent/ES2414455T3/es active Active
- 2006-10-10 KR KR1020087013112A patent/KR20080071581A/ko not_active Ceased
- 2006-10-10 KR KR1020137031255A patent/KR20130143729A/ko not_active Ceased
- 2006-10-10 EP EP20140163637 patent/EP2786748A1/en not_active Ceased
- 2006-10-10 SG SG2014014989A patent/SG2014014989A/en unknown
-
2008
- 2008-05-07 ZA ZA200803882A patent/ZA200803882B/xx unknown
- 2008-05-07 IL IL191311A patent/IL191311A/en active IP Right Grant
- 2008-05-20 MY MYPI2013003893A patent/MY162986A/en unknown
- 2008-05-26 EC EC2008008469A patent/ECSP088469A/es unknown
- 2008-05-28 GT GT200800075A patent/GT200800075A/es unknown
- 2008-05-30 TN TNP2008000238A patent/TNSN08238A1/en unknown
- 2008-06-02 MA MA30991A patent/MA30022B1/fr unknown
- 2008-06-18 NO NO20082753A patent/NO20082753L/no unknown
- 2008-10-16 AT AT0059308U patent/AT11185U1/de not_active IP Right Cessation
-
2013
- 2013-01-31 DK DKBA201300014U patent/DK201300014U3/da not_active IP Right Cessation
- 2013-01-31 DK DK201300015U patent/DK201300015Y4/da not_active IP Right Cessation
- 2013-04-12 DK DKBA201300059U patent/DK201300059U3/da not_active IP Right Cessation
- 2013-04-19 PH PH12013500772A patent/PH12013500772B1/en unknown
- 2013-04-19 PH PH12013500771A patent/PH12013500771A1/en unknown
- 2013-05-21 JP JP2013107198A patent/JP5938612B2/ja active Active
- 2013-05-31 US US13/906,922 patent/US20130266633A1/en not_active Abandoned
- 2013-06-10 FI FIU20134135U patent/FI10268U1/fi not_active IP Right Cessation
-
2014
- 2014-01-21 US US14/159,609 patent/US20140134230A1/en not_active Abandoned
- 2014-07-24 AR ARP140102752A patent/AR097045A2/es not_active Application Discontinuation
- 2014-08-25 IL IL234291A patent/IL234291A/en active IP Right Grant
- 2014-08-28 IL IL234364A patent/IL234364A/en active IP Right Grant
-
2015
- 2015-11-30 JP JP2015233544A patent/JP6298034B2/ja active Active
-
2016
- 2016-10-07 DK DKBA201600113U patent/DK201600113Y4/da not_active IP Right Cessation
-
2017
- 2017-02-23 IL IL250734A patent/IL250734A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009517468A5 (enExample) | ||
| JP6924298B2 (ja) | 経皮薬物送達組成物のためのシリコーン含有アクリルポリマー | |
| US10709669B2 (en) | Microreservoir system based on polysiloxanes and ambiphilic solvents | |
| JP6360494B2 (ja) | 積層型貼付剤 | |
| WO2006029740A3 (de) | Transdermales therapeutisches system mit einer haftschicht, verfahren zum silikonisieren einer rückschicht des systems und verwendung der rückschicht | |
| EP2636416A3 (en) | Phase-separated block copolymer coatings for implantable medical devices | |
| NO20091251L (no) | Nikotinisk acetylkolinreseptorsubtype selektive amider av diazabicykloalkaner | |
| KR20130060161A (ko) | 실리콘 아크릴레이트 하이브리드 조성물 및 그의 제조방법 | |
| NO20081253L (no) | Klebepreparat inneholdende bisopropol | |
| WO2009132656A3 (en) | Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin | |
| TW200833372A (en) | Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound | |
| HRP20201880T1 (hr) | Transdermalni terapijski sustav namijenjen primjeni aktivne tvari | |
| JP2013507487A5 (enExample) | ||
| CN106659702A (zh) | 透皮递送体系 | |
| JP2006528144A5 (enExample) | ||
| MY172157A (en) | Thioninium compounds and their use | |
| CN102579409A (zh) | 多奈哌齐经皮贴片 | |
| JP2011523650A5 (enExample) | ||
| JP2008512411A5 (enExample) | ||
| JP2014508810A5 (enExample) | ||
| CN106413695A (zh) | 利伐斯的明透皮组合物及其使用方法 | |
| TWI660751B (zh) | 貼附劑 | |
| IL176152A0 (en) | Percutaneous absorption-type pharmaceutical preparation | |
| MX2009008776A (es) | Agonistas de los receptores alfa2c adrenergicos funcionalmente selectivos. | |
| WO2018155390A1 (ja) | 貼付剤及びその包装体 |